JPS6384496A - Production of 4-oxopimelic acid monoester - Google Patents
Production of 4-oxopimelic acid monoesterInfo
- Publication number
- JPS6384496A JPS6384496A JP22926086A JP22926086A JPS6384496A JP S6384496 A JPS6384496 A JP S6384496A JP 22926086 A JP22926086 A JP 22926086A JP 22926086 A JP22926086 A JP 22926086A JP S6384496 A JPS6384496 A JP S6384496A
- Authority
- JP
- Japan
- Prior art keywords
- oxopimelic
- genus
- oxopimelic acid
- acid
- pseudomonas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- UDDSEESQRGPVIL-UHFFFAOYSA-N 4-oxoheptanedioic acid Chemical compound OC(=O)CCC(=O)CCC(O)=O UDDSEESQRGPVIL-UHFFFAOYSA-N 0.000 title abstract description 10
- 244000005700 microbiome Species 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 11
- 241000589516 Pseudomonas Species 0.000 claims abstract description 7
- 241000590020 Achromobacter Species 0.000 claims abstract description 6
- 241000186216 Corynebacterium Species 0.000 claims abstract description 6
- 241000589236 Gluconobacter Species 0.000 claims abstract description 6
- 241000588881 Chromobacterium Species 0.000 claims abstract description 5
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 4
- 241000589565 Flavobacterium Species 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims abstract description 4
- 241000186063 Arthrobacter Species 0.000 claims abstract description 3
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 230000001580 bacterial effect Effects 0.000 claims description 12
- -1 4- oxopimelic acid diester Chemical class 0.000 abstract description 9
- 150000005690 diesters Chemical class 0.000 abstract description 7
- 239000007864 aqueous solution Substances 0.000 abstract description 4
- 239000000872 buffer Substances 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 230000000813 microbial effect Effects 0.000 abstract 2
- 241000590035 Achromobacter lyticus Species 0.000 abstract 1
- 241001658024 Microbacterium chocolatum Species 0.000 abstract 1
- 238000000034 method Methods 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 239000002994 raw material Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- ZGBUXZJMZBBISR-UHFFFAOYSA-N diethyl 4-oxoheptanedioate Chemical compound CCOC(=O)CCC(=O)CCC(=O)OCC ZGBUXZJMZBBISR-UHFFFAOYSA-N 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- JYEYJELELKLPLO-UHFFFAOYSA-N 7-ethoxy-4,7-dioxoheptanoic acid Chemical compound CCOC(=O)CCC(=O)CCC(O)=O JYEYJELELKLPLO-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 241000589539 Brevundimonas diminuta Species 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- IUDRJCMDRZEFGO-UHFFFAOYSA-N dimethyl 4-oxoheptanedioate Chemical compound COC(=O)CCC(=O)CCC(=O)OC IUDRJCMDRZEFGO-UHFFFAOYSA-N 0.000 description 2
- ADGKRNQPSRFRMX-UHFFFAOYSA-N dipropyl 4-oxoheptanedioate Chemical compound CCCOC(=O)CCC(=O)CCC(=O)OCCC ADGKRNQPSRFRMX-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VGUWZCUCNQXGBU-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]-5-nitro-1h-indole Chemical compound C1CN(C)CCN1CC1=CNC2=CC=C([N+]([O-])=O)C=C12 VGUWZCUCNQXGBU-UHFFFAOYSA-N 0.000 description 1
- BGMLABWFIHLMPM-UHFFFAOYSA-N 4,7-dioxo-7-propoxyheptanoic acid Chemical compound CCCOC(=O)CCC(=O)CCC(O)=O BGMLABWFIHLMPM-UHFFFAOYSA-N 0.000 description 1
- CSFUHKWQBWYEHK-UHFFFAOYSA-N 7-butoxy-4,7-dioxoheptanoic acid Chemical compound CCCCOC(=O)CCC(=O)CCC(O)=O CSFUHKWQBWYEHK-UHFFFAOYSA-N 0.000 description 1
- NJWVCUDEAMWIFS-UHFFFAOYSA-N 7-methoxy-4,7-dioxoheptanoic acid Chemical compound COC(=O)CCC(=O)CCC(O)=O NJWVCUDEAMWIFS-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- NKRWXGPLRNMXKX-UHFFFAOYSA-N Coriolin Natural products CC1(C)CC2C(O)C3(CO3)C45OC4C(=O)C5(C)C2C1O NKRWXGPLRNMXKX-UHFFFAOYSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001524188 Glutamicibacter nicotianae Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 229930186686 Jasmolactone Natural products 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 241000589587 [Flavobacterium] lutescens Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- OMAFWWAJLVYWPU-ZOEJUPFXSA-N coriolin Chemical compound O=C([C@H]1O[C@]11[C@@H](O)[C@H]2CC([C@@H]([C@H]2[C@@]11C)O)(C)C)[C@]21CO2 OMAFWWAJLVYWPU-ZOEJUPFXSA-N 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- MBWFSTYYVKKLMK-UHFFFAOYSA-N dibutyl 4-oxoheptanedioate Chemical compound CCCCOC(=O)CCC(=O)CCC(=O)OCCCC MBWFSTYYVKKLMK-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- NBCMACYORPIYNY-UHFFFAOYSA-N jasmolactone Chemical compound CC=CCCC1CCCC(=O)O1 NBCMACYORPIYNY-UHFFFAOYSA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は微生物を利用した4−オキソピメリン酸モノエ
ステルの製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for producing 4-oxopimelic acid monoester using microorganisms.
[従来の技術および発明が解決しようとする問題点コ
近年、生理活性物質の合成が盛んに研究されているが、
それらを合成するに際して光学活性を有する物質は重要
な中間原料である。しかしながら、通常えられる化合物
は左旋性を有する6体と右旋性を有する9体とを1=1
の割合で含有するラセミ体であるため、光学活性な物質
をうるためには光学分割が必要となり、それゆえ光学活
性を有する物質の合成は難しい。したがって、不斉合成
が容易に起るような化合物、すなわち光学活性物質の原
料となる物質はいまだ数多く知られていない現状にある
。[Problems to be solved by conventional techniques and inventions In recent years, the synthesis of physiologically active substances has been actively researched.
Optically active substances are important intermediate raw materials in their synthesis. However, normally obtained compounds have 6 bodies with levorotatory properties and 9 bodies with dextrorotatory properties in a ratio of 1=1.
Since it is a racemic substance containing a ratio of Therefore, many compounds that can be easily synthesized asymmetrically, that is, substances that can be used as raw materials for optically active substances, are still unknown.
本発明の目的化合物である4−オキソピメリン酸モノエ
ステルは種々の有機化合物の原料となりうるが、とりわ
け光学活性物質あるいはその原料などの前駆体として有
用である。4-oxopimelic acid monoester, which is the object compound of the present invention, can be used as a raw material for various organic compounds, and is particularly useful as a precursor for optically active substances or raw materials thereof.
たとえば、つぎに示す化合物(It)〜■の前駆体とし
て有用である。For example, it is useful as a precursor for the following compounds (It) to (2).
前記式(1)の(R)−γ−ブチロラクトンーγ−プロ
ピオン酸エステルは、本発明のモノエステルに対して還
元能力を有する微生物を作用させることにより容易にえ
られる。式(II)の化合物の用途としてはつぎのよう
なものがあげられる。The (R)-γ-butyrolactone-γ-propionic acid ester of the formula (1) can be easily obtained by treating the monoester of the present invention with a microorganism having a reducing ability. Examples of uses of the compound of formula (II) include the following.
(1)ジャスモラクトン(天然香料であるジャスミン油
の主構成成分)の中間原料(フレグランス・ジャーナル
Nα77(198B)124〜129頁)(2)昆虫フ
ェロモンであるエルダツライドの原料(アグリ力ルチャ
ル・バイオロジカル・ケミスト リ − (Agri
c、Biol、Chea+、)4ニジ、 2775〜
277B(198B))
(3)白血病に対する医薬であるステガノドンの原料(
テトラヘドロン・レターズ(TetrahedronL
etters)21.2709(1980))前記化合
物(2)は本発明のエステルの分子内フリーデル・クラ
フッ反応によりえられるが(ケミッシJ−’ベリヒテ(
CheIl、Ber、 )100.297a 〜297
7(1967)) 、このものは抗腫瘍性物質であるコ
リオリンの原料となる(ザeジャーナル中オブ・オーガ
ニック・ケミストリー(J、Org、Chcv、)47
、2820(1982))。また化合物面を還元能力を
有する微生物あるいは不斉還元試薬により還元したのち
、さらにラクトン化することにより前記化合物Nがえら
れる。該化合物Nはプロスタグランディンの原料として
使用されているコーレイラクトン(Coreylact
on)の前駆体物質M1冊に誘導できる(ジャーナル・
オブ・ザ・アメリカン・ケミカル・ソサイアティ(J、
AIQer、Ches。(1) Intermediate raw material for jasmolactone (main component of jasmine oil, a natural fragrance) (Fragrance Journal Nα77 (198B) pp. 124-129) (2) Raw material for elderaturide, an insect pheromone (Agricultural Bio Logical Chemistry - (Agri
c, Biol, Chea+,) 4 Niji, 2775~
277B (198B)) (3) Raw material for steganodon, a drug for leukemia (
Tetrahedron Letters
etters) 21.2709 (1980)) The above compound (2) can be obtained by intramolecular Friedel-Krach reaction of the ester of the present invention (Kemissi J-'Berichte (1980)).
CheIl, Ber, ) 100.297a ~ 297
7 (1967)), which is a raw material for the antitumor substance Coriolin (The e-Journal of Organic Chemistry (J, Org, Chcv,) 47).
, 2820 (1982)). Further, the compound N can be obtained by reducing the compound surface with a microorganism having a reducing ability or an asymmetric reducing reagent, and then further lactonizing it. The compound N is derived from Coreylactone, which is used as a raw material for prostaglandin.
on) can be induced into one volume of precursor material (journal/
of the American Chemical Society (J.
AIQer, Ches.
Soc、) 95.8832(1973)) 、以上の
ように4−オキソピメリン酸モノエステルは、種々の有
用物質の前駆体として重要である。Soc, ) 95.8832 (1973)) As described above, 4-oxopimelic acid monoester is important as a precursor of various useful substances.
従来より脂肪族ジカルボン酸ジエステルからモノエステ
ルをうる方法としては、化学的に部分加水分解させる方
法、あるいはジエステルとジカルボン酸とを同じ比率で
混合しルイス酸などの触媒の存在下に加熱する方法など
がある。Conventional methods for obtaining monoesters from aliphatic dicarboxylic acid diesters include chemical partial hydrolysis, or mixing diester and dicarboxylic acid in the same ratio and heating in the presence of a catalyst such as a Lewis acid. There is.
しかしながら、これらの方法でえられる化合物から目的
物たるモノエステルをうるには蒸留その他の繁雑な分離
操作が必要であり、いまだ実用性に欠ける。その他の方
法としては、ジカルボン酸をアルミナに吸着させたのち
、ジアゾメタンでモノエステルを合成する方法が報告さ
れている(ジャーナルφオブ・ザ・アメリカン・ケミカ
ル・ソサイアティ(J、Amer、Chem、Soc、
)107、1385〜1389(1985))。しかし
ながら、該方法によれば卓上実験的規模でしか目的物を
合成できない。However, in order to obtain the desired monoester from the compound obtained by these methods, distillation and other complicated separation operations are required, and these methods are still impractical. Another method has been reported in which a dicarboxylic acid is adsorbed on alumina and then a monoester is synthesized with diazomethane (Journal φ of the American Chemical Society (J, Amer, Chem, Soc,
) 107, 1385-1389 (1985)). However, according to this method, the target product can only be synthesized on a benchtop experimental scale.
このように、4−オキソピメリン酸モノエステルを高収
率、高純度でかつ大量に製造する方法は開発されていな
かった。As described above, a method for producing 4-oxopimelic acid monoester in high yield, high purity, and in large quantities has not been developed.
[問題点を解決するための手段]
本発明者らは、叙上の問題点に着目し、温和な条件でし
かも簡易な操作によって高収率、高純度の4−オキソピ
メリン酸モノエステルを製造する方法を開発すべく鋭意
研究を重ねた。その結果、生化学的手法にもとづき4−
オキソピメリン酸ジエステルに微生物を作用させること
によって対応するモノエステルかえられることを見出し
、本発明を完成するにいたった。[Means for Solving the Problems] The present inventors focused on the above-mentioned problems and produced 4-oxopimelic acid monoester with high yield and high purity under mild conditions and with simple operations. We conducted extensive research to develop the method. As a result, based on biochemical methods, 4-
It was discovered that the corresponding monoester can be converted to oxopimelic acid diester by the action of microorganisms, leading to the completion of the present invention.
すなわち本発明は、一般式(■):
RO2CCll2CH2ecH2CII2C02R(1
)(式中、RはC1〜C4の低級アルキル基をあられす
)であられされる4−オキソピメリン酸ジエステルをア
クロモバクタ−(Achroa+obacter)属、
クロモバクテリウム(Chroa+obacter1u
m)属1フラボバクテリウム(Plavobacter
lum)属、グルコノバクタ−(Gluconobac
ter)属、シュードモナス(Pseudomonas
)属、アルスロバクタ−(Artl+robacter
)属、バシルス(Baclllus)属およびコリネバ
クテリウム(Corynebacter1ua+)属よ
りなる群から選ばれた属に属する微生物の培養物もしく
はその菌体に接触せしめることを特徴とする4−オキソ
ピメリン酸モノエステルの製造方法に関する。That is, the present invention provides general formula (■): RO2CCll2CH2ecH2CII2C02R(1
) (in the formula, R represents a lower alkyl group of C1 to C4), a 4-oxopimelic acid diester of the Achromobacter genus,
Chromobacterium (Chroa+obacter1u
m) Genus 1 Flavobacterium
lum), Gluconobacter (Gluconobacter)
ter) genus, Pseudomonas
) genus, Arthrobacter (Artl+robacter)
), Bacillus genus, and Corynebacterium genus Corynebacterium (Corynebacterium+). Regarding the method.
本発明の出発原料である4−オキソピメリン酸ジエステ
ル(1)は、たとえばつぎのような工程によってうろこ
とができる。4-oxopimelic acid diester (1), which is the starting material of the present invention, can be purified, for example, by the following steps.
(式中、Rは前記と同じ)
前段の反応では、フルフラールとマロン酸をアンモニア
、第一級、第二級アミンなどのような塩基性触媒の存在
下に脱水縮合させてフルフリルアクリル酸をうる。この
ばあい用いるアミンとしてはピリジンが好ましい。後段
の反応では、前段の反応でえられたフルフリルアクリル
酸をC1〜C4のアルコールに溶解後、強酸の存在下、
加熱還流することにより4−オキソピメリン酸ジエステ
ルをうることができる。ここでアルコールを適宜選択使
用することにより、それぞれに対応したエステル化合物
かえられる(ジャーナルーオブ・ケミカル・ソサイアテ
ィU。(In the formula, R is the same as above.) In the first reaction, furfural and malonic acid are dehydrated and condensed in the presence of a basic catalyst such as ammonia, primary or secondary amine to produce furfuryl acrylic acid. sell. The amine used in this case is preferably pyridine. In the latter reaction, after dissolving the furfuryl acrylic acid obtained in the first reaction in a C1 to C4 alcohol, in the presence of a strong acid,
4-oxopimelic acid diester can be obtained by heating under reflux. By appropriately selecting and using the alcohol, the corresponding ester compound can be changed (Journal of Chemical Society U.
Chem、Soc、) 78.3425(195B))
。Chem, Soc,) 78.3425 (195B))
.
なお4−オキソピメリン酸ジエステルの合成方法は上記
方法に限られることはなく、該ジエステルかえられる方
法であればいかなる方法であってもよい。Note that the method for synthesizing 4-oxopimelic acid diester is not limited to the above method, and any method may be used as long as the diester can be converted.
[作用および実施例]
えられた4−オキソピメリン酸ジエステルのモノエステ
ルへの変換は、該ジエステルをビッグリバ一二ステラー
ゼもしくは微生物の菌体に適当な方法で接触させること
により行なうことができる。用いる微生物の具体例とし
てはエステラーゼ活性の強い微生物、たとえばアクロモ
バクタ−Φリチクス(Achromobacter 1
ytlcus)IP0127251272B、シュード
モナス・ジミヌタ(Pseudomonas dlml
nuta) IPO1318113182、クロモバク
テリウム・チョコラタム
(Chromobacterium chocolat
um)IFO3578、フラボバクテリウム・ルテセン
ス(Flavobacter 1umlutescen
s)IFO3084、グルコノバクター争ジキソセトニ
カス(Gluconobacter dixyocet
onicus)IFO3271,シュードモナス・ジニ
トリフィカンス(PseudolIlonas din
ltr1f’1cans)IPO13302、アルスロ
バクタ−・ニコチアナエ(Arthrobactern
icotianae)IAM 12342、バシルス・
プミルス(Bacillus pumllus)IFo
3813、コリネバクテリウム0フアスシエンス(C
orynebacterium!’asclens)J
AM 1072などがあげられる。[Operations and Examples] The obtained 4-oxopimelic acid diester can be converted into a monoester by bringing the diester into contact with bigliba disterase or the cells of a microorganism by an appropriate method. Specific examples of microorganisms used include microorganisms with strong esterase activity, such as Achromobacter Φlyticus (Achromobacter 1).
ytlcus) IP0127251272B, Pseudomonas dlml
Nuta) IPO1318113182, Chromobacterium chocolat
um) IFO3578, Flavobacterium lutescens
s) IFO3084, Gluconobacter dixyocet
onicus) IFO3271, Pseudomonas dinitrificans (Pseudollonas din
ltr1f'1cans) IPO13302, Arthrobacter nicotianae
icotianae) IAM 12342, Bacillus
Bacillus pumillus IFo
3813, Corynebacterium 0 fuasciens (C
orynebacterium! 'asklens)J
Examples include AM 1072.
本発明の4−オキソピメリン酸モノエステルを製造する
には、まず上記微生物を適当な培地に接種し、バクテリ
アの通常の培養方法によって培養を行なう。たとえば、
肉エキス、グルコース、カゼイン分解物などを含む培地
で一定時間振とうまたは撹拌培養を行なって菌体を増殖
させる。ついで4−オキソピメリン酸ジエステルを添加
し、さらに培養を行なう。さらに、菌体を増殖させたの
ち、遠心分離などの操作によって菌体を分離後、新たに
該菌体にpH5〜9、好ましくは6〜8のバッファー水
溶液とともに前記出発物質を加えて反応させてもよい。In order to produce the 4-oxopimelic acid monoester of the present invention, the above-mentioned microorganism is first inoculated into a suitable medium and cultured using a conventional culture method for bacteria. for example,
The bacterial cells are grown by shaking or stirring culture for a certain period of time in a medium containing meat extract, glucose, casein decomposition product, etc. Then, 4-oxopimelic acid diester is added and further culture is performed. Furthermore, after the bacterial cells have been grown, the bacterial cells are separated by an operation such as centrifugation, and the starting material is newly added to the bacterial cells together with an aqueous buffer solution having a pH of 5 to 9, preferably 6 to 8, and reacted. Good too.
培養温度は通常20〜50℃、好ましくは25〜40℃
であり、培養時間は通常1〜120時間、好ましくは2
〜72時間が適当である。前記出発物質と菌体とを接触
させる方法としては、菌体に著しい損傷を与えない方法
であればいかなる方法であってもよく、たとえばカラギ
ーナン、コラーゲン、アルギン酸、寒天などのような一
般に知られている固定化担体、あるいはウレタン系、P
VA系、高吸水性樹脂、光硬化性樹脂などの合成ポリマ
ーに適当な方法で固定化して用いることができる。えら
れた培養物は、たとえば遠心分離などで菌体を除去した
のち上澄みをpH7〜1oに調整し、常法通り存機溶剤
で未反応のジエステルを抽出する。そののち水溶液をp
H2〜4に調整し、再び有機溶剤で抽出して乾燥、溶剤
留去すると4−オキソピメリン酸モノエステルかえられ
る。Culture temperature is usually 20-50°C, preferably 25-40°C
The culture time is usually 1 to 120 hours, preferably 2 hours.
~72 hours is appropriate. The method for bringing the starting material into contact with the bacterial cells may be any method as long as it does not cause significant damage to the bacterial cells. immobilization carrier, or urethane-based, P
It can be used by being immobilized on synthetic polymers such as VA-based resins, super absorbent resins, and photocurable resins by an appropriate method. After removing the bacterial cells from the obtained culture by, for example, centrifugation, the supernatant is adjusted to pH 7 to 1o, and unreacted diester is extracted with a residual solvent in a conventional manner. After that, the aqueous solution is
The mixture is adjusted to H2-4, extracted again with an organic solvent, dried, and the solvent is distilled off to obtain 4-oxopimelic acid monoester.
つぎに本発明を実施例を用いてさらに詳しく説明するが
、本発明はもとよりこれらに限定されるものではない。Next, the present invention will be explained in more detail using Examples, but the present invention is not limited to these.
実施例1
ペプトン肉エキス寒天斜面培地で30℃、48時間培養
したシュードモナス・ジミヌタIF013181の菌体
−白金耳を第1表に示す組成の培地10m1を分注した
2X18c+nの試験管に接種し、30℃で24時間振
とう培養を行なって種菌液を調製した。Example 1 A loopful of Pseudomonas diminuta IF013181 cells cultured on a peptone meat extract agar slant medium at 30°C for 48 hours was inoculated into a 2X18c+n test tube into which 10ml of a medium having the composition shown in Table 1 was dispensed. A seed culture solution was prepared by performing shaking culture at ℃ for 24 hours.
第 1 表
上記組成物と同じ液体培地100 mlを分注した5
00 ml坂ロフラスコに上記種菌液1 mlを接種し
、30℃で24時間培養した。合計700 mlの振と
ぅ培養でえられた菌体を遠心分離により集菌したものを
0.2Mリン酸バッファ −(pH8,5)350ml
に懸濁後、4−オキソピメリン酸ジエチルエステル17
.5gを加え、30”Cで72時間反応させた。反応終
了後pHをKOHで9.0に調整し、未反応の4−オキ
ソピメリン酸ジエチルエステルを抽出除去したのち、水
層を11 CIでpH2,0に調整しエチルエーテルで
抽出した。エーテル層を硫酸ナトリウムで乾燥後、減圧
留去し、4−オキソピメリン酸モノエチルエステル12
.5.を゛えた(収率81%)。Table 1 5. Dispense 100 ml of the same liquid medium as the above composition.
1 ml of the above inoculum solution was inoculated into a 00 ml Sakaro flask and cultured at 30°C for 24 hours. A total of 700 ml of bacterial cells obtained by shaking culture were collected by centrifugation and added to 350 ml of 0.2M phosphate buffer (pH 8.5).
4-oxopimelic acid diethyl ester 17
.. 5 g was added and reacted at 30"C for 72 hours. After the reaction was completed, the pH was adjusted to 9.0 with KOH, and unreacted 4-oxopimelic acid diethyl ester was extracted and removed, and the aqueous layer was diluted to pH 2 with 11 CI. , 0 and extracted with ethyl ether.The ether layer was dried over sodium sulfate and then distilled off under reduced pressure to give 4-oxopimelic acid monoethyl ester 12.
.. 5. (yield 81%).
該物質はNMRおよびTLCからほとんど純粋であり、
融点は67〜68℃であった。The material is nearly pure from NMR and TLC;
The melting point was 67-68°C.
’HNMR(80MIlz 、 CDCl a )δF
1.28(t 、3H)、2.74(m 、 8H
) 、−4,15(Q 、 2H) 、10.95(s
。'HNMR(80MIlz, CDCla)δF
1.28 (t, 3H), 2.74 (m, 8H
), -4,15(Q, 2H), 10.95(s
.
l11)
IR(neat) (cm−’ ):3100、1
740、171O1142゜実施例2
実施例1で培養したシュードモナス・ジミヌタIF01
3181の菌体を、0.2Mリン酸バッファ(p117
,5)350mlに懸濁後、4−オキソピメリン酸ジメ
チルエステル10.0gを加え、30℃で72時間反応
させた。反応終了後plをKOHで9.0に調整し、未
反応の4−オキソピメリン酸ジメチルエステルを抽出除
去したのち、水層をHCIでpH2,0に調整しエチル
エーテルで抽出した。エーテル層を硫酸ナトリウムで乾
燥後、減圧留去し、残渣をシリカゲルクロマトグラフィ
ー(MeOtl/クロロホルム−1710)で精製し、
無色油状の4−オキソピメリン酸モノメチルエステル5
.6gをえた(収率60%)。該物質はNMRおよびT
LCからほとんど純粋であった。l11) IR (neat) (cm-'): 3100, 1
740, 171O1142゜Example 2 Pseudomonas diminuta IF01 cultured in Example 1
3181 cells were added to 0.2M phosphate buffer (p117
, 5) After suspending in 350 ml, 10.0 g of 4-oxopimelic acid dimethyl ester was added, and the mixture was reacted at 30°C for 72 hours. After the reaction was completed, the pl was adjusted to 9.0 with KOH, and unreacted 4-oxopimelic acid dimethyl ester was extracted and removed, and the aqueous layer was adjusted to pH 2.0 with HCI and extracted with ethyl ether. After drying the ether layer with sodium sulfate, it was distilled off under reduced pressure, and the residue was purified by silica gel chromatography (MeOtl/chloroform-1710).
Colorless oily 4-oxopimelic acid monomethyl ester 5
.. 6 g was obtained (yield 60%). The material is NMR and T
Almost pure from LC.
’)I NMR(60MHz 5CDCI! 3 )
δ; 2.132(m 、8H)、3.62(s
、 311)、6.14(s 、 IH)IR(nea
t) (cm ’ ):3180.1730.1710
、■410410実
施施例1で培養したシュードモナスψジミヌタIP01
3181の菌体−白金耳を3%プレイン・ハート・イン
フュージョンlomlを分注した2×18cmの試験管
に接種し、30℃で24時間振とう培養を行なって種菌
液を調製した。')I NMR (60MHz 5CDCI! 3)
δ; 2.132 (m, 8H), 3.62 (s
, 311), 6.14(s, IH) IR(nea
t) (cm'): 3180.1730.1710
, ■410410 Pseudomonas ψ Jiminuta IP01 cultured in Example 1
A loopful of bacterial cells of 3181 was inoculated into a 2 x 18 cm test tube into which 3% plain heart infusion loml was dispensed, and cultured with shaking at 30°C for 24 hours to prepare an inoculum solution.
5%プレイン・ハート・インフュージョン100 ml
を分注した5 00 ml坂ロフラスコに上記種菌液1
mlを接種し30℃で24時間培養した。合計700
m1の振とう培養でえられた菌体を遠心分離により集菌
したものを0.2Mリン酸バッファー(pH8,0)3
50mlに懸濁後、4−オキソピメリン酸ジプロピルエ
ステル20.0gを加え、30℃で72時間反応させた
。反応終了後pnをKOHで9.0に調整し、未反応の
4−オキソピメリン酸ジプロピルエステルを抽出除去し
たのち、水層をHCI)でpH2,0に調整しエチルエ
ーテルで抽出した。エーテル層を硫酸ナトリウムで乾燥
後、減圧留去し、淡黄色の油状物である4−オキソピメ
リン酸モノプロピルエステル13.2gをえた(収率7
8%)。5% Plain Heart Infusion 100ml
The above inoculum solution 1 was dispensed into a 500 ml Sakalo flask.
ml was inoculated and cultured at 30°C for 24 hours. Total 700
Bacterial cells obtained by shaking culture of ml were collected by centrifugation and collected in 0.2M phosphate buffer (pH 8,0)3.
After suspending in 50 ml, 20.0 g of 4-oxopimelic acid dipropyl ester was added, and the mixture was reacted at 30°C for 72 hours. After the reaction was completed, pn was adjusted to 9.0 with KOH, unreacted 4-oxopimelic acid dipropyl ester was extracted and removed, and the aqueous layer was adjusted to pH 2.0 with HCI) and extracted with ethyl ether. The ether layer was dried over sodium sulfate and then evaporated under reduced pressure to obtain 13.2 g of 4-oxopimelic acid monopropyl ester as a pale yellow oil (yield 7).
8%).
該物質はNMRおよびTLCからほとんど純粋であった
。The material was nearly pure from NMR and TLC.
lII NMR(80MIIz 、 CDCJ 3 )
δ: 0.8B(t 、3H)、1.88(m
、 211)、2.74(m 、88)、4.05(t
。II NMR (80MIIz, CDCJ3)
δ: 0.8B (t, 3H), 1.88 (m
, 211), 2.74 (m, 88), 4.05 (t
.
2H) 、10.18(s 、 IH)IR(neat
) (cm −1) :3200.1735.1720
.1420実施例4
実施例3で培養したシュードモナス・ジミヌタIF01
3181の菌体を、0.2Mリン酸バッファ(pH8,
0)350mlに懸濁後、4−オキソピメリン酸ジブチ
ルエステル25.Ogを加えた以外は実施例1と同様の
操作を行ない、淡黄色の油状物である4−オキソピメリ
ン酸モノブチルエステル15.5gをえた(収率77%
)。該物質はNMRおよびTLCからほとんど純粋であ
った。2H), 10.18(s, IH)IR(neat
) (cm-1) :3200.1735.1720
.. 1420 Example 4 Pseudomonas diminuta IF01 cultured in Example 3
3181 cells in 0.2M phosphate buffer (pH 8,
0) After suspending in 350 ml, 4-oxopimelic acid dibutyl ester 25. The same operation as in Example 1 was carried out except that Og was added, and 15.5 g of 4-oxopimelic acid monobutyl ester, which was a pale yellow oil, was obtained (yield 77%).
). The material was nearly pure from NMR and TLC.
’HNMR(60MHz 5CDCJ 3 )δ:
0.95(t 、 311)、1.85(11,411
) 、 2.87(+ 、 811) 、 4
.07(t 。'HNMR (60MHz 5CDCJ3) δ:
0.95 (t, 311), 1.85 (11,411
), 2.87(+, 811), 4
.. 07(t.
211)、 7.54(s 5III)IR(ne
at)(c+n −1):3220.1740.172
0.1410実施例5
ペプトン肉エキス寒天斜面培地で28℃、24時間培養
したフラボバクテリウム・ルテセンスIFO3085の
菌体−白金耳を第1表に示す組成の培地10m1を分注
した2 X 18cmの試験管に接種し、30℃で24
時間振とう培養を行なって種菌液を調製した。211), 7.54 (s 5III) IR (ne
at)(c+n-1):3220.1740.172
0.1410 Example 5 A loopful of Flavobacterium lutecens IFO3085 cells cultured on a peptone meat extract agar slant medium at 28°C for 24 hours was placed in a 2 x 18 cm square. Inoculate test tubes and incubate at 30℃ for 24 hours.
An inoculum solution was prepared by performing shaking culture for a period of time.
上記組成物と同じ液体培地100 mlを分注した5
00 ml坂ロフラスコに上記種菌液1 mlを接種し
、30℃で36時間培養した。合計1gの振とう培養で
えられた菌体を遠心分離により集菌したものを0.2M
リン酸バッファ (1)118.0)500mlに懸
濁後、4−オキソピメリン酸ジエチルエステル5.0g
を加え、30℃で72時間反応させた。反応終了後、実
施例1と同様の操作で処理したのち、4−オキソピメリ
ン酸モノエチルエステル1.2gをえた(収率27%)
。該物質はNMRおよびTLCからほとんど純粋であり
、融点は67〜B8℃であった。5. Dispense 100 ml of the same liquid medium as the above composition.
1 ml of the above inoculum solution was inoculated into a 00 ml Sakaro flask and cultured at 30°C for 36 hours. A total of 1g of bacterial cells obtained by shaking culture was collected by centrifugation, and 0.2M
After suspending in 500 ml of phosphate buffer (1) 118.0), 5.0 g of 4-oxopimelic acid diethyl ester
was added and reacted at 30°C for 72 hours. After the reaction was completed, 1.2 g of 4-oxopimelic acid monoethyl ester was obtained after processing in the same manner as in Example 1 (yield 27%).
. The material was nearly pure by NMR and TLC, with a melting point of 67-B8°C.
’HNMR(80MHz 、 CDCJ 3 )δ:
1.28(t 、3H)、2.74(+ 、8H)
、’ 4.15(q 、 2H) 、10.95(s
。'HNMR (80MHz, CDCJ3) δ:
1.28 (t, 3H), 2.74 (+, 8H)
,' 4.15(q, 2H), 10.95(s
.
lII)
IR(neat) (、cm−1):3100.174
0.1710.1420実施例6
実施例5と同様の方法により培養したクロモバクテリウ
ム・ココラツムIF0375gの菌体を、0.2Mリン
酸バッファ −(pH7,5)500mlに懸濁後、4
−オキソピメリン酸ジエチルエステル2.0gを加えた
以外は実施例5と同様の操作を行ない、4−オキソピメ
リン酸モノエチルエステル0.8gをえた(収率34%
)。該物質はNMRおよびTLCからほとんど純粋であ
り、融点は67〜68℃であった。lII) IR(neat) (, cm-1): 3100.174
0.1710.1420 Example 6 After suspending 375 g of Chromobacterium cocolatum IF0 cells cultured in the same manner as in Example 5 in 500 ml of 0.2 M phosphate buffer (pH 7.5),
-The same operation as in Example 5 was carried out except that 2.0 g of oxopimelic acid diethyl ester was added, and 0.8 g of 4-oxopimelic acid monoethyl ester was obtained (yield 34%).
). The material was nearly pure by NMR and TLC, with a melting point of 67-68<0>C.
’HNMR(60MHz %CDC13)δ: 1.
2g(t 、 311)、2.74(a 、 8H)、
4.15(q 、 2H) 、10.95(s 。'HNMR (60MHz %CDC13) δ: 1.
2g (t, 311), 2.74 (a, 8H),
4.15 (q, 2H), 10.95 (s.
IH)
IR(neat)(cm’ ):3100.1740.
1710.1420実施例7
0.05Mリン酸バッフy (pH8,0)100
mlを300 mlの三角フラスコに分注し、25℃
の恒温水槽でインキュベート後、ビッグリバーエステラ
ーゼ(シグマ社製) 1800単位および4−オキソピ
メリン酸ジエチルエステル1gを加えて撹拌した。希に
011水溶液でpHを7.0〜8.0に保ちながら、合
計4.0gの4−オキソピメリン酸ジエチルエステルを
加え6時間反応させた。反応終了後、希KOH水溶液で
p)110.0に調整し、以下実施例1と同様の操作で
処理したのち、4−オキソピメリン酸モノエチルエステ
ル3.4gをえた(収率9B%)。該物質はNMRおよ
びTLCからほとんど純粋であり、融点は67〜68℃
であった。IH) IR (neat) (cm'): 3100.1740.
1710.1420 Example 7 0.05M phosphoric acid buffer y (pH 8,0) 100
Dispense ml into a 300 ml Erlenmeyer flask and incubate at 25°C.
After incubation in a thermostatic water bath, 1800 units of Big River Esterase (manufactured by Sigma) and 1 g of 4-oxopimelic acid diethyl ester were added and stirred. A total of 4.0 g of 4-oxopimelic acid diethyl ester was added and reacted for 6 hours while keeping the pH at 7.0 to 8.0 with dilute 011 aqueous solution. After the reaction was completed, the p) was adjusted to 110.0 with a dilute KOH aqueous solution and treated in the same manner as in Example 1 to obtain 3.4 g of 4-oxopimelic acid monoethyl ester (yield: 9B%). The material is nearly pure from NMR and TLC, with a melting point of 67-68°C.
Met.
’HNMR(BOMHz 、 CDCJ 3 ) δ
: 1.28(t 、3H)、2.74(Ill、
8H)、4.15(q 、 2H) 、10.95(s
。'HNMR (BOMHz, CDCJ3) δ
: 1.28 (t, 3H), 2.74 (Ill,
8H), 4.15(q, 2H), 10.95(s
.
IH)
IR(neat) (cm ’ ) :3100.17
40.1710.1420[発明の効果]
本発明の方法によれば4−オキソピメリン酸モノエステ
ルを温和な反応条件でしかも高収率かつ高純度で容易に
合成することができる。IH) IR (neat) (cm'): 3100.17
40.1710.1420 [Effects of the Invention] According to the method of the present invention, 4-oxopimelic acid monoester can be easily synthesized under mild reaction conditions with high yield and high purity.
Claims (1)
す)であらわされる4−オキソピメリン酸ジエステルを
アクロモバクター(Achromobacter)属、
クロモバクテリウム(Chromobacterium
)属、フラボバクテリウム(Flavobacteri
um)属、グルコノバクター(Gluconobact
er)属、シュードモナス(Pseudomonas)
属、アルスロバクター(Arthrobacter)属
、バシルス(Bacillus)属およびコリネバクテ
リウム (Corynebacterium)属よりなる群から
選ばれた属に属する微生物の培養物もしくはその菌体に
接触せしめることを特徴とする4−オキソピメリン酸モ
ノエステルの製造方法。[Claims] 1. General formula (I): ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R represents a lower alkyl group of C_1 to C_4) Bacter (Achromobacter) genus,
Chromobacterium
) genus, Flavobacterium
um) genus, Gluconobacter (Gluconobacter)
er) genus, Pseudomonas
4, characterized in that it is brought into contact with a culture of a microorganism or its bacterial cells belonging to a genus selected from the group consisting of the genus Arthrobacter, Bacillus, and Corynebacterium. - A method for producing oxopimelic acid monoester.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22926086A JPS6384496A (en) | 1986-09-26 | 1986-09-26 | Production of 4-oxopimelic acid monoester |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22926086A JPS6384496A (en) | 1986-09-26 | 1986-09-26 | Production of 4-oxopimelic acid monoester |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6384496A true JPS6384496A (en) | 1988-04-15 |
JPH044872B2 JPH044872B2 (en) | 1992-01-29 |
Family
ID=16889325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22926086A Granted JPS6384496A (en) | 1986-09-26 | 1986-09-26 | Production of 4-oxopimelic acid monoester |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6384496A (en) |
-
1986
- 1986-09-26 JP JP22926086A patent/JPS6384496A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH044872B2 (en) | 1992-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0044158B1 (en) | Novel optically active imidazolidin-2-one derivatives and their production | |
FR2473519A1 (en) | TERPENOIDS CONTAINING TWO FUNCTIONAL GROUPS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
US4343814A (en) | Hypocholesterolemic fermentation products | |
US4432996A (en) | Hypocholesterolemic fermentation products and process of preparation | |
JPS61146191A (en) | Production of (s)-gamma-halo-beta-hydroxybutyric acid ester | |
US5773240A (en) | Optically active α-substituted carboxylic acid derivatives and method for producing the same | |
JPS6384496A (en) | Production of 4-oxopimelic acid monoester | |
JPS5946598B2 (en) | Production method of long-chain fatty acids using microorganisms | |
US5591853A (en) | Products of a microbiological process for the production of 2-halo-pyrimidine-4-carboxylic acids | |
JPH06256278A (en) | Optically active alpha-carbamoylalkanoic acid derivative and its production | |
US4613571A (en) | Polyprenyl sulfone derivatives and process for producing the same | |
JPS61289899A (en) | Production of optically active 2-halo-1-phenyl-ethanol and ester thereof | |
US3873529A (en) | Novel antibiotic ascofuranone and process for the production thereof | |
EP0168480A1 (en) | Process for preparing optically-active 4-amino-3-hydroxybutyric acid | |
US4456558A (en) | Polyprenyl ketone derivatives | |
JPH04126089A (en) | Production of 4-oxopimelic acid monoester | |
JPH01132393A (en) | Production of pimelic acid monoester derivative | |
JPH0369279B2 (en) | ||
WO1999060151A1 (en) | New biotechnological process for preparing hydroxylated ml-236b derivatives, known as m-4 and m-4', and analogues thereof | |
JPS5945360B2 (en) | Production method of physiologically active substance ML-236B | |
JP3069965B2 (en) | Method for producing dialcohol | |
EP0431970A2 (en) | Process for producing optically active R-(+)-2, 3,-dichloro-1-propanol using microorganism | |
JPS6363387A (en) | Production of (r)-butyrolactone-gamma-propionic acid ester | |
JPS63202398A (en) | Production of optically active cyanohydrin derivative | |
JPH03236796A (en) | Optical resolution method by enzyme |